Thyrogen
Product Images NDC 58468-1849

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Thyrogen (NDC 58468-1849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Thyrogen 01)

This text appears to be a list of medical symptoms and terms, possibly related to a certain condition. Some of the symptoms listed include diminished sweating, dry skin, weight increase, constipation, and paresthesia. The presence of terms like "thyrogen" and "withdrawal phase" suggest that this may be related to thyroid disease or treatment. However, the output contains numerous errors and misspellings, making it difficult to interpret accurately.*

FDA Label Image

Figure 2 (Thyrogen 02)

FDA Label Image

Package Label (Principal Display Panel – 4 vial Carton)

This text describes a medication called Thyrotropin alfa, containing 0.9mg/vial, for intramuscular injection only. The medication should be refrigerated at 2°C to 8°C and protected from light. The single-dose solution can be diluted with Sterile Water for Injection, USP, and used within 3 hours of reconstitution. The vials come packaged with information such as lot number, expiry date, and dosage instructions. This medication is manufactured by Genzyme Corporation based in Cambridge, MA 02142.*

FDA Label Image

Package Label (Principal Display Panel – 2 vial Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.